Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
Identifieur interne : 000050 ( Pmc/Curation ); précédent : 000049; suivant : 000051Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
Auteurs : Rosa Zampino ; Nicola Coppola ; Caterina Sagnelli ; Giovanni Di Caprio ; Evangelista SagnelliSource :
- World Journal of Hepatology [ 1948-5182 ] ; 2015.
Abstract
The studies on hepatitis C virus (HCV) infection in prison populations are few and mostly cross-sectional. We analyzed prevalently the articles appearing on PubMed in the last ten years. HCV infection is frequent in prisoners, prevalences ranging from 3.1% to 38% according to the HCV endemicity in the geographical location of the prison and in the countries of origin of the foreign prisoners and to the prevalence of intravenous drug use, which is the most important risk factor for HCV infection, followed by an older age of prisoners and previous prison terms. HCV replication in anti-HCV-positive cases varies from 45% to 90% in different studies, and the most common HCV genotypes are generally 1 and 3. The response to antiviral treatment is similar in prisoners to that of the general population. Unfortunately, treatment is administered less frequently to prisoners because of the difficulties in management and follow-up. The new directly acting antivirals offer a good therapy option for inmates because of their good efficacy, short duration of treatment and low incidence of side effects. The efforts of the prison authorities and medical staff should be focused on reducing the spread of HCV infection in prisons by extending the possibility of follow-up and treatment to more prisoners with chronic hepatitis C.
Url:
DOI: 10.4254/wjh.v7.i21.2323
PubMed: 26413221
PubMed Central: 4577639
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000050
Links to Exploration step
PMC:4577639Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment</title><author><name sortKey="Zampino, Rosa" sort="Zampino, Rosa" uniqKey="Zampino R" first="Rosa" last="Zampino">Rosa Zampino</name></author><author><name sortKey="Coppola, Nicola" sort="Coppola, Nicola" uniqKey="Coppola N" first="Nicola" last="Coppola">Nicola Coppola</name></author><author><name sortKey="Sagnelli, Caterina" sort="Sagnelli, Caterina" uniqKey="Sagnelli C" first="Caterina" last="Sagnelli">Caterina Sagnelli</name></author><author><name sortKey="Di Caprio, Giovanni" sort="Di Caprio, Giovanni" uniqKey="Di Caprio G" first="Giovanni" last="Di Caprio">Giovanni Di Caprio</name></author><author><name sortKey="Sagnelli, Evangelista" sort="Sagnelli, Evangelista" uniqKey="Sagnelli E" first="Evangelista" last="Sagnelli">Evangelista Sagnelli</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26413221</idno><idno type="pmc">4577639</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577639</idno><idno type="RBID">PMC:4577639</idno><idno type="doi">10.4254/wjh.v7.i21.2323</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000050</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000050</idno><idno type="wicri:Area/Pmc/Curation">000050</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000050</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment</title><author><name sortKey="Zampino, Rosa" sort="Zampino, Rosa" uniqKey="Zampino R" first="Rosa" last="Zampino">Rosa Zampino</name></author><author><name sortKey="Coppola, Nicola" sort="Coppola, Nicola" uniqKey="Coppola N" first="Nicola" last="Coppola">Nicola Coppola</name></author><author><name sortKey="Sagnelli, Caterina" sort="Sagnelli, Caterina" uniqKey="Sagnelli C" first="Caterina" last="Sagnelli">Caterina Sagnelli</name></author><author><name sortKey="Di Caprio, Giovanni" sort="Di Caprio, Giovanni" uniqKey="Di Caprio G" first="Giovanni" last="Di Caprio">Giovanni Di Caprio</name></author><author><name sortKey="Sagnelli, Evangelista" sort="Sagnelli, Evangelista" uniqKey="Sagnelli E" first="Evangelista" last="Sagnelli">Evangelista Sagnelli</name></author></analytic><series><title level="j">World Journal of Hepatology</title><idno type="ISSN">1948-5182</idno><idno type="eISSN">1948-5182</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The studies on hepatitis C virus (HCV) infection in prison populations are few and mostly cross-sectional. We analyzed prevalently the articles appearing on PubMed in the last ten years. HCV infection is frequent in prisoners, prevalences ranging from 3.1% to 38% according to the HCV endemicity in the geographical location of the prison and in the countries of origin of the foreign prisoners and to the prevalence of intravenous drug use, which is the most important risk factor for HCV infection, followed by an older age of prisoners and previous prison terms. HCV replication in anti-HCV-positive cases varies from 45% to 90% in different studies, and the most common HCV genotypes are generally 1 and 3. The response to antiviral treatment is similar in prisoners to that of the general population. Unfortunately, treatment is administered less frequently to prisoners because of the difficulties in management and follow-up. The new directly acting antivirals offer a good therapy option for inmates because of their good efficacy, short duration of treatment and low incidence of side effects. The efforts of the prison authorities and medical staff should be focused on reducing the spread of HCV infection in prisons by extending the possibility of follow-up and treatment to more prisoners with chronic hepatitis C.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">World J Hepatol</journal-id><journal-id journal-id-type="publisher-id">WJH</journal-id><journal-title-group><journal-title>World Journal of Hepatology</journal-title></journal-title-group><issn pub-type="ppub">1948-5182</issn><issn pub-type="epub">1948-5182</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26413221</article-id><article-id pub-id-type="pmc">4577639</article-id><article-id pub-id-type="other">jWJH.v7.i21.pg2323</article-id><article-id pub-id-type="doi">10.4254/wjh.v7.i21.2323</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zampino</surname><given-names>Rosa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Coppola</surname><given-names>Nicola</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sagnelli</surname><given-names>Caterina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Di Caprio</surname><given-names>Giovanni</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sagnelli</surname><given-names>Evangelista</given-names></name></contrib><aff>Rosa Zampino, Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Internal Medicine, Second University Naples, 80135 Naples, Italy</aff><aff>Nicola Coppola, Giovanni Di Caprio, Department of Mental Health and Public Medicine, Section of Infectious Diseases, Second University Naples, 80135 Naples, Italy</aff><aff>Caterina Sagnelli, Department of Clinical and Experimental Medicine and Surgery “F. Magrassi e A. Lanzara”, Second University Naples, 80135 Naples, Italy</aff><aff>Evangelista Sagnelli, Department of Mental Health and Public Medicine, Second University Naples, 80135 Naples, Italy</aff></contrib-group><author-notes><fn><p>Author contributions: Zampino R had conceived and drafted the article, and approved the final version; Sagnelli C and Di Caprio G reviewed the literature, contributed to drafting the article and approved the final version; Coppola N and Sagnelli E critically reviewed the manuscript and approved the final version of this article.</p><p>Correspondence to: Rosa Zampino, MD, PhD, Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Internal Medicine, Second University Naples, Via Pansini 5, Edificio 3, 80135 Naples, Italy. <email>rosa.zampino@unina2.it</email></p><p>Telephone: +39-81-5666708 Fax: +39-81-5666707</p></fn></author-notes><pub-date pub-type="ppub"><day>28</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>28</day><month>9</month><year>2015</year></pub-date><volume>7</volume><issue>21</issue><fpage>2323</fpage><lpage>2330</lpage><history><date date-type="received"><day>23</day><month>4</month><year>2015</year></date><date date-type="rev-recd"><day>5</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>7</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2015</copyright-year></permissions><abstract><p>The studies on hepatitis C virus (HCV) infection in prison populations are few and mostly cross-sectional. We analyzed prevalently the articles appearing on PubMed in the last ten years. HCV infection is frequent in prisoners, prevalences ranging from 3.1% to 38% according to the HCV endemicity in the geographical location of the prison and in the countries of origin of the foreign prisoners and to the prevalence of intravenous drug use, which is the most important risk factor for HCV infection, followed by an older age of prisoners and previous prison terms. HCV replication in anti-HCV-positive cases varies from 45% to 90% in different studies, and the most common HCV genotypes are generally 1 and 3. The response to antiviral treatment is similar in prisoners to that of the general population. Unfortunately, treatment is administered less frequently to prisoners because of the difficulties in management and follow-up. The new directly acting antivirals offer a good therapy option for inmates because of their good efficacy, short duration of treatment and low incidence of side effects. The efforts of the prison authorities and medical staff should be focused on reducing the spread of HCV infection in prisons by extending the possibility of follow-up and treatment to more prisoners with chronic hepatitis C.</p></abstract><kwd-group><kwd>Prisoners</kwd><kwd>Management</kwd><kwd>Treatment</kwd><kwd>Care</kwd><kwd>Chronic hepatitis C</kwd></kwd-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/TelematiV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= TelematiV1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:4577639
|texte= Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:26413221" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a TelematiV1
| This area was generated with Dilib version V0.6.31. |  |